Toward improvements for carrying capacity of the cyclodextrin-based nanosponges: recent progress from a material and drug delivery

被引:28
作者
Deng, Jing [1 ,2 ]
Chen, Qi Jue [2 ]
Li, Wen [1 ,2 ]
Zuberi, Zavuga [3 ]
Feng, Jian Xiang [2 ]
Lin, Qin Lu [1 ]
Ren, Jia Li [1 ]
Luo, Fei Jun [1 ]
Ding, Quan Ming [2 ]
Zeng, Xiao Xi [2 ]
Ma, Liang [2 ]
Yin, Hua Qun [4 ]
Zheng, Xiang Min [2 ]
机构
[1] Cent South Univ Forestry & Technol, Natl Engn Lab Deep Proc Rice & Byprod, Hunan Prov Key Lab Edible Forestry Resources Safe, Coll Food Sci & Engn,Hunan Key Lab Processed Food, Changsha 410004, Hunan, Peoples R China
[2] Hunan Univ Technol, Coll Life Sci & Chem, Coll Packaging & Mat Engn, Zhuzhou 412007, Hunan, Peoples R China
[3] Dar Es Salaam Inst Technol, Dept Sci & Lab Technol, POB 2958, Dar Es Salaam, Tanzania
[4] Cent South Univ, Sch Resource Proc & Bioengn, Changsha 410083, Hunan, Peoples R China
基金
国家重点研发计划;
关键词
BETA-CYCLODEXTRIN; L-DOPA; PARKINSON DISEASE; ORAL DELIVERY; FORMULATION; WATER; CURCUMIN; RELEASE; BIOAVAILABILITY; SOLUBILITY;
D O I
10.1007/s10853-020-05646-8
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Cyclodextrins are a type of natural materials that can be used in the pharmaceutical industry. Cyclodextrins are safe, biodegradable, with the multifunctional property as they can encapsulate both hydrophilic and hydrophobic drugs. Additionally, they can overcome challenges associated with drug toxicity and enhancing the solubility of the insoluble drugs; thus, cyclodextrins are effective carriers in loading tiny molecules. Moreover, the synthesis of nanosponges (NPs) systems can enhance the drug encapsulation in cyclodextrin cavities to control the rate of drug released. Cyclodextrin can contain the drug molecules to form a clathrate; cyclodextrin-based NPs can maintain a high loading capacity of various small molecules for drug delivery. This review presents a general overview of the current research progress and the applications of cyclodextrin-based NPs for drug delivery in the past two decades.
引用
收藏
页码:5995 / 6015
页数:21
相关论文
共 115 条
  • [1] Combined hydroxypropyl-β-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel
    Agueeros, M.
    Ruiz-Gaton, L.
    Vauthier, C.
    Bouchemal, K.
    Espuelas, S.
    Ponchel, G.
    Irache, J. M.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (04) : 405 - 413
  • [2] Role of β-cyclodextrin nanosponges in polypropylene photooxidation
    Alongi, Jenny
    Poskovic, Merima
    Frache, Alberto
    Trotta, Francesco
    [J]. CARBOHYDRATE POLYMERS, 2011, 86 (01) : 127 - 135
  • [3] Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study
    Ansari, Khalid A.
    Vavia, Pradeep R.
    Trotta, Francesco
    Cavalli, Roberta
    [J]. AAPS PHARMSCITECH, 2011, 12 (01): : 279 - 286
  • [4] Ansari R., 2014, DRUG DELIV LETT, V4, P148, DOI [10.2174/2210303104666140313232454, DOI 10.2174/2210303104666140313232454]
  • [5] Bachkar B.A., 2015, WORLD J PHARM RES, V4, P751
  • [6] Antimicrobial-loaded nanocarriers for food packaging applications
    Bahrami, Akbar
    Delshadi, Rana
    Assadpour, Elham
    Jafari, Seid Mahdi
    Williams, Leonard
    [J]. ADVANCES IN COLLOID AND INTERFACE SCIENCE, 2020, 278
  • [7] Targets and pathways involved in the antitumor activity of citral and its stereo-isomers
    Bailly, Christian
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 871
  • [8] Synthesis of new ionic β-cyclodextrin polymers and characterization of their heavy metals retention
    Berto, S.
    Bruzzoniti, M. C.
    Cavalli, R.
    Perrachon, D.
    Prenesti, E.
    Sarzanini, C.
    Trotta, F.
    Tumiatti, W.
    [J]. JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2007, 57 (1-4) : 631 - 636
  • [9] A concise review on cancer treatment methods and delivery systems
    Bidram, Elham
    Esmaeili, Yasaman
    Ranji-Burachaloo, Hadi
    Al-Zaubai, Nuha
    Zarrabi, Ali
    Stewart, Alastair
    Dunstan, Dave E.
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 54
  • [10] Bilensoy E, 2010, PHARM SCI ENCY DRUG, P2343, DOI [10.1002/9780470571224.PSE370, DOI 10.1002/9780470571224.PSE370]